What to do with "surprise" N2? Intraoperative management of patients with non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 3, Issue 3, 2008, Pages 289-302

  Detterbeck, Frank ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Mediastinal lymph node dissection; N2; Non small cell lung cancer; Stage IIIa; Surgery; Surprise

Indexed keywords

NAVELBINE;

ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPHADENOPATHY; MEDIASTINUM LYMPH NODE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW;

EID: 43249108821     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181630ebd     Document Type: Article

References (101)

1. AC Kiser FC Detterbeck General aspects of surgical treatment FC Detterbeck MP Rivera MA Socinski Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician 2001 W.B. Saunders Philadelphia, PA 133 147
2. LJ Kohman JA Meyer PM Ikins Random versus predictable risks of mortality after thoracotomy for lung cancer J Thorac Cardiovasc Surg 9 1986 551 554
3. G Deneffe LM Lacquet E Verbeken Surgical treatment of bronchogenic carcinoma: a retrospective study of 720 thoracotomies Ann Thorac Surg 45 1988 380 383
4. JL Duque G Ramos J Castrodeza Early complications in surgical treatment of lung cancer: a prospective, multicenter study Ann Thorac Surg 63 1997 944 950
5. JMM Van den Bosch HJ Gelissen SS Wagenaar Exploratory thoracotomy in bronchial carcinoma J Thorac Cardiovasc Surg 85 1983 733 737
6. SS Steinbaum ID Uretzky HP McAdams Exploratory thoracotomy for nonresectable lung cancer Chest 107 1995 1058 1061
7. R Rami-Porta M Mateu-Navarro J Freixinet Type of resection and prognosis in lung cancer. Experience of a multicentre study Eur J Cardiothorac Surg 28 2005 622 628
8. D Fang D Zhang G Huang Results of surgical resection of patients with primary lung cancer: a retrospective analysis of 1,905 cases Ann Thorac Surg 72 2001 1155 1159
9. S Watanabe H Asamura K Suzuki Recent results of postoperative mortality for surgical resections in lung cancer Ann Thorac Surg 78 2004 999 1002 discussion 1002–1003.
10. MS Allen G Darling T Pechet Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial Ann Thorac Surg 81 2006 1013 1020
11. RE Dales R Belanger FM Shamji Quality-of-life following thoracotomy for lung cancer J Clin Epidemiol 47 1994 1443 1449
12. E Nõu T Aberg Quality of survival in patients with surgically treated bronchial carcinoma Thorax 35 1980 255 263
13. F Detterbeck MA Socinski S Gettinger Lung neoplasms J Norton PS Barie RR Bollinger Surgery: Basic Science and Clinical Evidence 2008 Springer-Verlag New York In press.
14. J Wang J Olak RE Ultmann Assessment of pulmonary complications after lung resection Ann Thorac Surg 67 1999 1444 1447
15. PG Boysen JO Harris AJ Block Prospective evaluation for pneumonectomy using perfusion scanning: follow-up beyond one year Chest 80 1981 163 166
16. HU Zieren JM Muller U Hamberger Quality of life after surgical therapy of bronchogenic carcinoma Eur J Cardiothorac Surg 10 1996 233 237
17. G Myrdal S Valtysdottir M Lambe Quality of life following lung cancer surgery Thorax 58 2003 194 197
18. JR Handy Jr JW Asaph L Skokan What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery Chest 122 2002 21 30
19. F Detterbeck M Jantz M Wallace Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 202S 220S
20. F Detterbeck Integration of mediastinal staging techniques for lung cancer Semin Thorac Cardiovasc Surg 19 2007 217 224
21. T Naruke Significance of lymph node metastases in lung cancer Semin Thorac Cardiovasc Surg 5 1993 210 218
22. M Coughlin J Deslauriers M Beaulieu Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer Ann Thorac Surg 40 1985 556 560
23. FG Pearson NC DeLarue R Ilves Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung J Thorac Cardiovasc Surg 83 1982 1 11
24. K Suzuki K Nagai J Yoshida The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status J Thorac Cardiovasc Surg 118 1999 145 153
25. JF Régnard P Magdeleinat D Azoulay Results of resection for bronchogenic carcinoma with mediastinal lymph node metastases in selected patients Eur J Cardiothorac Surg 5 1991 583 587
26. R Nakanishi T Osaki K Nakanishi Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancer Ann Thorac Surg 64 1997 342 348
27. JF Vansteenkiste PR DeLeyn GJ Deneffe Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases Ann Thorac Surg 63 1997 1441 1450
28. DL Miller KG McManus MS Allen Results of surgical resection of patients with N2 non-small cell lung cancer Ann Thorac Surg 57 1994 1095 1101
29. F Andre D Grunenwald JP Pignon Survival of patients with resected N2 non small cell lung cancer (NSCLC): heterogeneity of prognosis and evidences for a subclassification (Abstract) J Clin Oncol 18 2000 2981 2989
30. G Maggi C Casadio R Cianci Results of surgical resection of stage IIIA (N2) non small cell lung cancer, according to the site of the mediastinal metastases Int Surg 78 1993 213 217
31. M Riquet D Manac'h M Saab Factors determining survival in resected N2 lung cancer Eur J Cardiothorac Surg 9 1995 300 304
32. Y Watanabe Y Hayashi J Shimizu Mediastinal nodal involvement and the prognosis of non-small cell lung cancer Chest 100 1991 422 428
33. PA Thomas S Piantadosi CF Mountain Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? J Thorac Cardiovasc Surg 95 1988 883 887
34. F Tanaka K Yanagihara Y Ohtake Time trends and survival after surgery for p-stage IIIa, pN2 non-small cell lung cancer (NSCLC) Eur J Cardiothorac Surg 12 1997 372 379
35. Y Watanabe J Shimizu M Oda Aggressive surgical intervention in N2 non-small cell cancer of the lung Ann Thorac Surg 51 1991 253 261
36. T Ishida M Tateishi S Kaneko Surgical treatment of patients with nonsmall-cell lung cancer and mediastinal lymph node involvement J Surg Oncol 43 1990 161 166
37. RJ van Klaveren J Festen HJAM Otten Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer Ann Thorac Surg 56 1993 300 304
38. AG Little V Rusch J Bonner Patterns of surgical care of lung cancer patients Ann Thorac Surg 80 2005 2051 2056
39. M Zielinski Transcervical extended mediastinal lymphadenectomy: results of staging in two hundred fifty-six patients with non-small cell lung cancer J Thorac Oncol 2 2007 370 372
40. FC Detterbeck DR Jones Surgical treatment of stage IIIa (N2) non-small cell lung cancer FC Detterbeck MP Rivera MA Socinski Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician 2001 W. B. Saunders Philadelphia, PA 244 256
41. P Goldstraw GC Mannam DK Kaplan Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease) J Thorac Cardiovasc Surg 107 1994 19 28
42. P De Leyn P Schoonooghe G Deneffe Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease) Eur J Cardiothorac Surg 10 1996 649 655
43. S-I Watanabe G Ladas P Goldstraw Inter-observer variability in systematic nodal dissection: comparison of European and Japanese nodal designation Ann Thorac Surg 73 2002 245 248
44. M Zielinski R Rami-Porta Proposals for changes in the Mountain and Dresler mediastinal and pulmonary lymph node map J Thorac Oncol 2 2007 3 6
45. N Martini BJ Flehinger MB Zaman Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases Ann Surg 198 1983 386 397
46. Y Ichinose H Kato T Koike Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials Lung Cancer 34 2001 29 36
47. CF Mountain Expanded possibilities for surgical treatment of lung cancer: survival in stage IIIa disease Chest 97 1990 1045 1051
48. H Wada F Tanaka K Yanagihara Time trends and survival after operations for primary lung cancer from 1976 through 1990 J Thorac Cardiovasc Surg 112 1996 349 355
49. VW Rusch J Crowley D Giroux The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 603 612
50. JF Vansteenkiste PR DeLeyn GJ Deneffe Clinical prognostic factors in surgically treated stage IIIA-N2 non-small cell lung cancer: analysis of the literature Lung Cancer 19 1998 3 13
51. GA Patterson D Piazza FG Pearson Significance of metastatic disease in subaortic lymph nodes Ann Thorac Surg 43 1987 155 159
52. Y Sakao H Miyamoto A Yamazaki The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy Eur J Cardiothorac Surg 30 2006 543 547
53. M Okada N Tsubota M Yoshimura Prognosis of completely resected pN2 non-small cell lung carcinomas: what is the significant node that affects survival? J Thorac Cardiovasc Surg 118 1999 270 275
54. G Maggi Results of radical treatment of stage IIIa non-small-cell carcinoma of the lung Eur J Cardiothorac Surg 2 1988 329 335
55. IJ Cybulsky LA Lanza MB Ryan Prognostic significance of computed tomography in resected N2 lung cancer Ann Thorac Surg 54 1992 533 537
56. FC Detterbeck TM Egan Surgery for stage II non-small cell lung cancer FC Detterbeck MP Rivera MA Socinski Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician 2001 W. B. Saunders Philadelphia PA 191 197
57. PE Van Schil AB de la Riviere PJ Knaepen TNM staging and long-term follow-up after sleeve resection for bronchogenic tumors Ann Thorac Surg 52 1991 1096 1101
58. RJ Mehran J Deslauriers M Piraux Survival related to nodal status after sleeve resection for lung cancer J Thorac Cardiovasc Surg 107 1994 576 583
59. T Naruke Bronchoplastic and bronchovascular procedures of the tracheobronchial tree in the management of primary lung cancer Chest 96 1989 53S 56S
60. HA Gaissert DJ Mathisen AC Moncure Survival and function after sleeve lobectomy for lung cancer J Thorac Cardiovasc Surg 111 1996 948 953
61. EA Rendina F Venuta T De Giacomo Sleeve resection and prosthetic reconstruction of the pulmonary artery for lung cancer Ann Thorac Surg 68 1999 995 1002
62. M Okada H Yamagishi S Satake Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy J Thorac Cardiovasc Surg 119 2000 814 819
63. D Lardinois P De Leyn P Van Schil ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer Eur J Cardiothorac Surg 30 2006 787 792
64. JAR Gaer P Goldstraw Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus Eur J Cardiothorac Surg 4 1990 207 210
65. ECM Bollen CJ van Duin PHMH Theunissen Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging Ann Thorac Surg 55 1993 961 966
66. JR Izbicki B Passlick K Pantel Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer Ann Surg 227 1998 138 144
67. K Sugi K Nawata N Fujita Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter World J Surg 22 1998 290 294
68. Y Wu ZF Huang SY Wang A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer Lung Cancer 36 2002 1 6
69. L Robinson J Ruckdeschel H Wagner Treatment of non-small cell lung cancer—stage IIIA: ACCP evidence-based guidelines (2nd edition) Chest 132 2007 243S 265S
70. W Scott J Howington S Feigenberg Treatment of non-small cell lung cancer—stage I & II: ACCP evidence-based clinical practice guideline (2nd edition) Chest 132 2007 234S 242S
71. JR Izbicki B Passlick O Karg Impact on radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer Ann Thorac Surg 59 1995 209 214
72. R Manser G Wright D Hart Surgery for early stage non-small cell lung cancer Cochrane Database Syst Rev 25 2005 CD004699
73. SM Keller S Adak H Wagner Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer; from the Eastern Cooperative Oncology Group Ann Thorac Surg 70 2000 358 365
74. T Funatsu Y Matsubara S Ikeda Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer J Thorac Cardiovasc Surg 108 1994 321 328
75. T Berghmans M Paesmans AP Meert Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature Lung Cancer 49 2005 13 23
76. J-Y Douillard R Rosell M De Lena Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 2006 719 727
77. PORT Meta-analysis Trialists Group Postoperative radiotherapy in non-small-cell lung cancer: systemic review and meta-analysis of individual patient data from nine randomised controlled trials Lancet 352 1998 257 263
78. MA Socinski FC Detterbeck JG Rosenman Adjuvant therapy of resected non-small cell lung cancer FC Detterbeck MP Rivera MA Socinski Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician 2001 W. B. Saunders Philadelphia, PA 206 219
79. G Okawara YC Ung BR Markman Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline Lung Cancer 44 2004 1 11
80. BE Lally D Zelterman JM Colasanto Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database J Clin Oncol 24 2006 2998 3006
81. TA Hensing JS Halle MA Socinki Chemoradiotherapy for stage IIIa, b non-small cell lung cancer FC Detterbeck MP Rivera MA Socinski Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician 2001 W. B. Saunders Philadelphia, PA 291 303
82. JR Jett SE Schild RL Keith Treatment of non-small cell lung cancer—stage IIIb: ACCP evidenced-based clinical practice guidelines Chest 132 2007 266S 276S
83. K Albain CB Scott VR Rusch Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): initial results from intergroup trial 0139 (RTOG 93–09) (Abstract) Proc Am Soc Clin Oncol 22 2003 621
84. H West KS Albain Current standards and ongoing controversies in the management of locally advanced non-small cell lung cancer Semin Oncol 32 2005 284 292
85. FC Detterbeck MA Socinski Induction therapy and surgery for I–IIIa, b non-small cell lung cancer FC Detterbeck MP Rivera MA Socinski Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician 2001 W. B. Saunders Philadelphia, PA 257 266
86. MA Socinski JG Rosenman J Halle Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma Cancer 92 2001 1213 1223
87. MA Socinski DE Morris JS Halle Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial J Clin Oncol 22 2004 4341 4350
88. N Alam F Sheherd T Winton Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer: an analysis of National Cancer Institute of Canada and intergroup trial JBR. 10 and a review of the literature Lung Cancer 47 2005 385 394
89. MK Ferguson Optimal management when unsuspected N2 nodal disease is identified during thoracotomy for lung cancer: cost-effectiveness analysis J Thorac Cardiovasc Surg 126 2003 1935 1942
90. G Maggi C Casadio M Mancuso Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases Int Surg 75 1990 17 21
91. M Inoue N Sawabata S Takeda Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe J Thorac Cardiovasc Surg 127 2004 1100 1106
92. F Rea G Marulli D Callegaro Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Lung Cancer 45 2004 215 220
93. A Iwasaki T Shirakusa T Miyoshi Prognostic significance of subcarinal station in non-small cell lung cancer with T1–3 N2 disease Thorac Cardiovasc Surg 54 2006 42 46
94. M Okada N Tsubota M Yoshimura Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis Ann Thorac Surg 68 1999 326 331
95. C Conill J Astudillo E Verger Prognostic significance of metastases to mediastinal lymph node levels in resected non-small cell lung carcinoma Cancer 72 1993 1199 1202
96. F Tanaka K Yanagihara Y Otake Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer Ann Surg Oncol 11 2004 612 618
97. Y Ohta Y Shimizu H Minato Results of initial operations in non–small cell lung cancer patients with single-level N2 disease Ann Thorac Surg 81 2006 427 433
98. BDT Daly JD Mueller LJ Faling N2 lung cancer: outcome in patients with false-negative computed tomographic scans of the chest J Thorac Cardiovasc Surg 105 1993 904 911
99. Y Sakao H Miyamoto A Yamazaki Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer Ann Thorac Surg 81 2006 292 297
100. Y Ichinose H Kato T Koike Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station J Thorac Cardiovasc Surg 122 2001 803 808
101. CF Mountain Surgery for stage IIIa-N2 non-small cell lung cancer Cancer 73 1994 2589 2598